Summary

The global market for cold chain products in plasma fractionation is estimated to grow significantly. By 2027, it is projected to reach a value of USD 711 million, showing a compound annual growth rate (CAGR) of 4.5% during the forecast period, starting from USD 569 million in 2022. The expansion of the cold chain products market is driven by various factors, including increasing concerns regarding zoonotic diseases, growing utilization of immunoglobulins and other plasma products in diverse therapeutic areas, and a rising demand for plasma-derived medicinal products. The industry for cold chain products is expected to progress due to the increasing need for plasma freezers and other cold chain products, as well as the adoption of advanced cold storage devices. These advancements in technology contribute to the overall growth and development of the cold chain products sector.
“Ultra-low temperature freezer segment was dominated by the highest share in Cold Chain Products Market for Plasma Fractionation” The market for Cold Chain Products for Plasma Fractionation is divided into seven types such as Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator, and Others. The Ultra-low temperature freezer segment accounted for the highest share of the global Cold Chain Products for Plasma Fractionation in 2021. Increasing Demand for Plasma-Derived Medicinal Products, Advancements in Plasma Fractionation Technologies, and Growing Need for Cold Chain Infrastructure all some of the factors that are anticipated to promote market expansion throughout the projected period.

"Blood collection centers and blood component providers accounted for the fastest growing segment of the Cold Chain Products Market for Plasma Fractionation in 2021."
The Cold Chain Products Market for Plasma Fractionation is divided into Blood collection centers and blood component providers, Hospitals and transfusion centers, Clinical research laboratories, and Others based on end users. In 2021, Blood collection centers and blood component providers held the highest market share for cold chain products for plasma fractionation. Growing demand for plasma fractionation, rising awareness and screening for blood-borne diseases, and expansion of healthcare infrastructure are some of the factors that contribute to the big proportion of this market.

"Latin America is expected to witness the fastest growth in the forecast period." In the forecast period, Latin America in the Cold Chain Products Market for Plasma Fractionation will have the fastest rising regional growth. Large number of hospitals and healthcare facilities, increasing spread of chronic diseases such as immune deficiencies, hemophilia, and autoimmune disorders are the main factors driving market growth. The rise of these illnesses in Latin America has resulted in a higher requirement for plasma freezers and refrigerators to preserve vital medical resources. In response to growing healthcare needs, advancements in medical treatments, and a growing understanding of the advantages of plasma-based products, the plasma fractionation sector in Latin America has been expanding. This expansion drives the need for suitable storage devices, such as plasma freezers and refrigerators.
Following is a list of the major players (supply-side) in the Cold Chain Products Market for Plasma Fractionation that this study refers to: By Company Type: Tier 1- 34%, Tier 2- 46%, and Tier 3- 20% By Designation: C-level- 35%, Director Level—25%, and Others- 40% By Region: North America-30%, Europe-45%, Asia Pacific-20%, Latin America- 3%, and Middle East and Africa-2% Several of the major companies in the market for Cold Chain Products for Plasma Fractionation include B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)

Research Coverage:

The market study analyzes the main market segments for cold chain products. The objective of this study is to estimate the market's size and growth potential across several categories according to type, end user, and region. The report also provides a thorough competition analysis of the major market participants, together with company profiles, major insights regarding their product and service offerings, recent advancements, and key market strategies.

Key Benefits of Buying the Report:
The study provides data regarding the cold chain products market's closest approximations and its segments, which will benefit market leaders and new entrants. This study will assist stakeholders in comprehending the competitive environment, obtaining insights to better position of their businesses, and developing appropriate go-to-market strategies. The research will also assist stakeholders in obtaining insights into the market's pulse and learning about its major drivers, inhibitors, opportunities, and problems.

The report provides insights on the following pointers:
Analysis of key drivers (Rising use of immunoglobulins and other plasma products in a range of therapeutic area, Increasing demand for Plasma-derived medicinal products, and Technological advancements in refrigeration equipment and systems), opportunities (Demand for Plasma Fractionation Centre and Government support for cold chain infrastructure development), and challenges (Shortage of trained manpower & limited resources to maintain the equipment, Stringent government regulations, and Environmental concerns regarding greenhouse gas emissions) influencing the growth of the Cold Chain Products Market for Plasma Fractionation.


Product Development/innovation:
Comprehensive details on new technologies, R&D initiatives, and product and service launches for Cold Chain Products Market for Plasma Fractionation

Market Development:
Comprehensive data on attractive markets, and the research analyzes the global Cold Chain Products Market for Plasma Fractionation

Market Diversification:
Detailed information on emerging products and services, unexplored regions, current trends, and investments in the Cold Chain Products Market for Plasma Fractionation.

Competitive Assessment:
Comprehensive analysis of market shares, growth plans, and service offerings of major companies operating in the Cold Chain Products Market for Plasma Fractionation like B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)

ページTOPに戻る

Table of Contents

1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.2.1 INCLUSIONS AND EXCLUSIONS 22
1.3 MARKET SCOPE 23
FIGURE 1 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION SEGMENTATION 23
FIGURE 2 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION 23
1.3.1 YEARS CONSIDERED 24
1.4 CURRENCY CONSIDERED 24
1.5 STAKEHOLDERS 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH APPROACH 26
FIGURE 3 RESEARCH DESIGN 26
2.1.1 SECONDARY DATA 27
2.1.1.1 Key data from secondary sources 27
2.1.2 PRIMARY DATA 28
FIGURE 4 PRIMARY SOURCES 28
2.1.2.1 Key data from primary sources 29
2.1.2.2 Key industry insights 30
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 30
2.2 MARKET SIZE ESTIMATION 31
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 31
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: THERMO FISHER SCIENTIFIC (US) 32
FIGURE 8 SUPPLY-SIDE ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION (2021) 32
FIGURE 9 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: BOTTOM-UP APPROACH 33
FIGURE 10 DRIVERS, OPPORTUNITIES, AND CHALLENGES (2022–2027): IMPACT ON MARKET GROWTH AND CAGR 34
FIGURE 11 CAGR PROJECTIONS 34
FIGURE 12 TOP-DOWN APPROACH 35
2.3 LIMITATIONS 35
2.3.1 METHODOLOGY-RELATED LIMITATIONS 36
2.3.2 MARKET BREAKDOWN & DATA TRIANGULATION 36
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 36
2.4 MARKET SHARE ANALYSIS 37
2.5 STUDY ASSUMPTIONS 37
2.6 RISK ASSESSMENT 38
2.7 RECESSION IMPACT ANALYSIS 38
3 EXECUTIVE SUMMARY 39
FIGURE 14 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2022 VS. 2027 (USD MILLION) 39
FIGURE 15 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2022 VS. 2027 (USD MILLION) 40
FIGURE 16 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: GEOGRAPHIC SNAPSHOT 41
4 PREMIUM INSIGHTS 42
4.1 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: MARKET OVERVIEW 42
FIGURE 17 RISING USE OF IMMUNOGLOBULINS AND OTHER PLASMA PRODUCTS TO DRIVE MARKET GROWTH 42
4.2 ASIA PACIFIC: COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION, BY TYPE & COUNTRY (2021) 43
FIGURE 18 ULTRA-LOW-TEMPERATURE FREEZERS TO HOLD LARGEST MARKET SHARE 43
4.3 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC GROWTH OPPORTUNITIES 44
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD 44
4.4 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC MIX 44
FIGURE 20 NORTH AMERICA TO DOMINATE MARKET OVER FORECAST PERIOD 44
4.5 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: DEVELOPING VS. DEVELOPED COUNTRIES 45
FIGURE 21 DEVELOPING COUNTRIES TO PRESENT GROWTH OPPORTUNITIES TO MARKET PLAYERS DURING THE FORECAST PERIOD 45
5 MARKET OVERVIEW 46
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
FIGURE 22 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
5.2.1 DRIVERS 46
5.2.1.1 Rising use of immunoglobulins and other plasma products 46
FIGURE 23 WORLDWIDE POLYVALENT IMMUNE GLOBULIN SALES FROM 2010 TO 2026 47
5.2.1.2 Increasing demand for plasma-derived medicinal products to treat chronic diseases 47
TABLE 1 PLASMA-DERIVED MEDICINAL PRODUCTS AND THEIR CLINICAL INDICATIONS 48
5.2.1.3 Technological advancements in refrigeration equipment and systems 48
5.2.2 OPPORTUNITIES 49
5.2.2.1 Demand for plasma fractionation centers 49
FIGURE 24 PLASMA FRACTIONATION PLANTS WORLDWIDE (2018) 49
5.2.2.2 Government support for cold chain infrastructure development 50
5.2.3 CHALLENGES 50
5.2.3.1 Shortage of trained manpower and limited resources to maintain equipment 50
5.2.3.2 Stringent government regulations 50
5.2.3.3 Environmental concerns regarding greenhouse gas emissions 51
5.3 PRICING ANALYSIS 51
5.3.1 AVERAGE SELLING PRICE OF COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE 51
TABLE 2 AVERAGE SELLING PRICE OF COLD CHAIN PRODUCTS, BY TYPE (USD) 51
5.3.2 AVERAGE SELLING PRICE TRENDS 52
5.4 SUPPLY CHAIN ANALYSIS 52
FIGURE 25 SUPPLY CHAIN ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION 52
5.5 ECOSYSTEM ANALYSIS 53
FIGURE 26 ECOSYSTEM ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION 54
5.6 PATENT ANALYSIS 54
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2013–MARCH 2023) 54
FIGURE 28 TOP APPLICANTS (COMPANIES/INSTITUTES) FOR COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION PATENTS (2013–2023) 55
5.7 VALUE CHAIN ANALYSIS 55
FIGURE 29 VALUE CHAIN ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION 56
5.8 TECHNOLOGY ANALYSIS 56
5.8.1 KEY TECHNOLOGY 56
5.8.1.1 Ultra-low freezer technology 56
5.8.2 ADJACENT TECHNOLOGY 57
5.8.2.1 Cryopreservation 57
5.9 REGULATORY LANDSCAPE 57
5.9.1 REGULATORY ANALYSIS 57
5.9.1.1 North America 57
5.9.1.2 Europe 58
5.9.1.3 Asia Pacific 58
5.9.1.4 Latin America 59
5.9.1.5 Middle East and Africa 59
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATION 60
TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 5 ASIA PACIFIC AND ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
5.10 PORTER’S FIVE FORCES ANALYSIS 62
TABLE 6 PORTER’S FIVE FORCES ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION 62
5.10.1 INTENSITY OF COMPETITIVE RIVALRY 63
5.10.2 BARGAINING POWER OF SUPPLIERS 63
5.10.3 BARGAINING POWER OF BUYERS 63
5.10.4 THREAT OF NEW ENTRANTS 63
5.10.5 THREAT OF SUBSTITUTES 64
5.11 KEY CONFERENCES AND EVENTS, 2023–2024 64
TABLE 7 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: KEY CONFERENCES AND EVENTS, 2023–2024 64
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 65
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 65
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION 65
TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES OF COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION 65
5.12.2 BUYING CRITERIA 66
TABLE 9 KEY BUYING CRITERIA FOR TOP THREE TYPES OF COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION 66
5.13 TRADE ANALYSIS 67
TABLE 10 EXPORTS OF COLD CHAIN STORAGE LABORATORY EQUIPMENT (2022) 67
TABLE 11 IMPORTS OF COLD CHAIN STORAGE LABORATORY EQUIPMENT (2022) 68
5.14 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: RECESSION IMPACT 69
6 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE 70
6.1 INTRODUCTION 71
TABLE 12 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 71
TABLE 13 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION) 72
6.2 ULTRA-LOW-TEMPERATURE FREEZERS 72
6.2.1 RISING DEMAND IN PLASMA STORAGE APPLICATIONS TO DRIVE MARKET GROWTH 72
TABLE 14 ULTRA-LOW-TEMPERATURE FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 73
6.3 PLASMA FREEZERS 74
6.3.1 RISING DEMAND IN SCIENTIFIC AND THERAPEUTIC APPLICATIONS TO BOOST GROWTH 74
TABLE 15 PLASMA FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74
6.4 TEMPERATURE MONITORING DEVICES 75
6.4.1 ADOPTION OF NOVEL TECHNOLOGIES IN TEMPERATURE MONITORING DEVICES TO PROPEL MARKET 75
TABLE 16 TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 76
6.5 PLASMA CONTACT SHOCK FREEZERS 76
6.5.1 NEED FOR RAPID FREEZING IN PLASMA TRANSPORT TO DRIVE MARKET 76
TABLE 17 PLASMA CONTACT SHOCK FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 77
6.6 BLOOD TRANSPORT BOXES 77
6.6.1 RISING ADOPTION OF TEMPERATURE-CONTROLLED BOXES TO TRANSPORT PLASMA FRACTIONATED COMPOUNDS TO DRIVE MARKET 77
TABLE 18 BLOOD TRANSPORT BOXES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 78
6.7 ICE-LINED REFRIGERATORS 78
6.7.1 COST-EFFECTIVENESS TO PROPEL END-USER ADOPTION 78
TABLE 19 ICE-LINED REFRIGERATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 79
6.8 OTHER PRODUCTS 79
TABLE 20 OTHER COLD CHAIN PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
7 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER 81
7.1 INTRODUCTION 82
TABLE 21 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 82
7.2 BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS 82
7.2.1 RISING DEMAND FOR PLASMA-DERIVED PRODUCTS TO DRIVE MARKET GROWTH 82
TABLE 22 COLD CHAIN PRODUCTS MARKET FOR BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION) 83
7.3 HOSPITALS & TRANSFUSION CENTERS 83
7.3.1 NEED TO ENSURE SAFE COLLECTION, STORAGE, AND COLD CHAIN MANAGEMENT OF PLASMA TO DRIVE MARKET GROWTH 83
TABLE 23 COLD CHAIN PRODUCTS MARKET FOR HOSPITALS & TRANSFUSION CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 84
7.4 CLINICAL RESEARCH LABORATORIES 84
7.4.1 ROLE OF LABS IN PLASMA FRACTIONATION AND COLD CHAIN PRODUCT DEVELOPMENT TO BOOST MARKET GROWTH 84
TABLE 24 COLD CHAIN PRODUCTS MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 85
7.5 OTHER END USERS 85
TABLE 25 COLD CHAIN PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 86
8 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION 87
8.1 INTRODUCTION 88
FIGURE 31 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: GEOGRAPHIC GROWTH OPPORTUNITIES 88
TABLE 26 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION, 2020–2027 (USD MILLION) 89
8.2 NORTH AMERICA 89
8.2.1 NORTH AMERICA: RECESSION IMPACT 89
FIGURE 32 NORTH AMERICA: LABORATORY FREEZERS MARKET SNAPSHOT 90
TABLE 27 NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION) 90
TABLE 28 NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 91
TABLE 29 NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 91
8.2.2 US 92
8.2.2.1 US to hold largest share of North American market 92
TABLE 30 US: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 92
TABLE 31 US: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 93
8.2.3 CANADA 93
8.2.3.1 Growing pharma R&D and increasing use of plasma-derived compounds to boost market 93
TABLE 32 CANADA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 94
TABLE 33 CANADA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 94
8.3 EUROPE 95
8.3.1 EUROPE: RECESSION IMPACT 95
TABLE 34 EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION) 95
TABLE 35 EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 96
TABLE 36 EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 96
8.3.2 GERMANY 97
8.3.2.1 Germany to dominate European market 97
TABLE 37 GERMANY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 97
TABLE 38 GERMANY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 98
8.3.3 FRANCE 98
8.3.3.1 Growing biotech & pharma industry and high prevalence of bleeding disorders to drive market 98
TABLE 39 FRANCE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 99
TABLE 40 FRANCE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 99
8.3.4 UK 100
8.3.4.1 Rising incidence of hemophilia and growing consumption of coagulation factors to propel market 100
TABLE 41 UK: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 42 UK: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 101
8.3.5 ITALY 101
8.3.5.1 Strong pharma sector and rising geriatric population to support market 101
TABLE 43 ITALY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 44 ITALY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 102
8.3.6 SPAIN 103
8.3.6.1 Rising chronic disease prevalence to boost demand 103
TABLE 45 SPAIN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 103
TABLE 46 SPAIN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 104
8.3.7 REST OF EUROPE 104
TABLE 47 REST OF EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 48 REST OF EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 105
8.4 ASIA PACIFIC 106
8.4.1 ASIA PACIFIC: RECESSION IMPACT 106
FIGURE 33 APAC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION SNAPSHOT 107
TABLE 49 ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 50 ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 51 ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 109
8.4.2 CHINA 109
8.4.2.1 China to dominate Asia Pacific market 109
TABLE 52 CHINA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 53 CHINA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 110
8.4.3 JAPAN 111
8.4.3.1 Growing aging population and rising prevalence of neurological disorders to propel growth 111
TABLE 54 JAPAN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 111
TABLE 55 JAPAN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 112
8.4.4 INDIA 112
8.4.4.1 Growing pharma-biotech industry to drive demand 112
TABLE 56 INDIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 57 INDIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 113
8.4.5 SOUTH KOREA 114
8.4.5.1 Rising awareness, advancements in medical treatments, and aging population to drive market 114
TABLE 58 SOUTH KOREA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 59 SOUTH KOREA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 115
8.4.6 AUSTRALIA 115
8.4.6.1 Rising demand for plasma products to treat chronic diseases to propel market 115
TABLE 60 AUSTRALIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 61 AUSTRALIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 116
8.4.7 REST OF ASIA PACIFIC 117
TABLE 62 REST OF ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 63 REST OF ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 118
8.5 LATIN AMERICA 118
8.5.1 RISING INVESTMENTS IN BRAZIL AND GROWING DISEASE PREVALENCE ACROSS LATAM TO BOOST MARKET 118
8.5.2 LATIN AMERICA: RECESSION IMPACT 118
TABLE 64 LATIN AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 65 LATIN AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 119
8.6 MIDDLE EAST & AFRICA 120
8.6.1 INFRASTRUCTURAL DEVELOPMENT IN HEALTHCARE TO OFFER GROWTH OPPORTUNITIES 120
8.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 120
TABLE 66 MIDDLE EAST & AFRICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 67 MIDDLE EAST & AFRICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 121
9 COMPETITIVE LANDSCAPE 122
9.1 OVERVIEW 122
9.2 KEY PLAYER STRATEGIES 122
TABLE 68 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION 123
9.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION 124
FIGURE 34 REVENUE ANALYSIS FOR KEY PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION MARKET 124
9.4 MARKET SHARE ANALYSIS 125
FIGURE 35 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021 125
TABLE 69 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: DEGREE OF COMPETITION 126
FIGURE 36 R&D ASSESSMENT OF KEY PLAYERS 127
9.5 COMPANY EVALUATION QUADRANT (KEY COMPANIES), 2021 127
9.5.1 STARS 127
9.5.2 PERVASIVE PLAYERS 127
9.5.3 EMERGING LEADERS 127
9.5.4 PARTICIPANTS 128
FIGURE 37 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: COMPANY EVALUATION MATRIX, 2021 128
9.6 COMPETITIVE BENCHMARKING 129
TABLE 70 OVERALL COMPANY FOOTPRINT 129
TABLE 71 COMPANY FOOTPRINT ANALYSIS, BY TYPE 130
TABLE 72 COMPANY FOOTPRINT ANALYSIS, BY END USER 131
TABLE 73 COMPANY FOOTPRINT ANALYSIS, BY REGION 132
9.7 COMPETITIVE SCENARIO 133
9.7.1 PRODUCT LAUNCHES & APPROVALS 133
TABLE 74 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–MARCH 2023 133
9.7.2 DEALS 134
TABLE 75 DEALS, JANUARY 2021–MARCH 2023 134
9.7.3 OTHER DEVELOPMENTS 134
TABLE 76 OTHER DEVELOPMENTS, JANUARY 2019– MARCH 2023 134
10 COMPANY PROFILES 135
(Business overview, Products offered, Recent Developments, MNM view)*
10.1 KEY PLAYERS 135
10.1.1 THERMO FISHER SCIENTIFIC, INC. 135
TABLE 77 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 135
FIGURE 38 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 136
10.1.2 HAIER BIOMEDICAL (HAIER GROUP) 139
TABLE 78 HAIER BIOMEDICAL: BUSINESS OVERVIEW 139
FIGURE 39 HAIER BIOMEDICAL (HAIER GROUP): COMPANY SNAPSHOT (2021) 140
10.1.3 EPPENDORF SE 143
TABLE 79 EPPENDORF AG: BUSINESS OVERVIEW 143
FIGURE 40 EPPENDORF AG: COMPANY SNAPSHOT 144
10.1.4 B MEDICAL SYSTEMS (AZENTA) 147
TABLE 80 B. MEDICAL SYSTEM (AZENTA): BUSINESS OVERVIEW 147
FIGURE 41 B MEDICAL SYSTEMS (AZENTA): COMPANY SNAPSHOT (2021) 148
10.1.5 BLUE STAR LIMITED 150
TABLE 81 BLUE STAR LIMITED: BUSINESS OVERVIEW 150
FIGURE 42 BLUE STAR LIMITED: COMPANY SNAPSHOT 151
TABLE 82 BLUE STAR LIMITED: PRODUCTS OFFERED 151
10.1.6 AVANTOR, INC. 153
TABLE 83 AVANTOR, INC.: BUSINESS OVERVIEW 153
FIGURE 43 AVANTOR, INC.: COMPANY SNAPSHOT 154
10.1.7 GODREJ AND BOYCE MANUFACTURING CO. LTD. 156
TABLE 84 GODREJ AND BOYCE MANUFACTURING CO. LTD.: BUSINESS OVERVIEW 156
FIGURE 44 GODREJ AND BOYCE MANUFACTURING CO. LTD.: COMPANY SNAPSHOT 156
10.1.8 BIOLIFE SOLUTIONS 158
TABLE 85 BIOLIFE SOLUTIONS: BUSINESS OVERVIEW 158
FIGURE 45 BIOLIFE SOLUTIONS: COMPANY SNAPSHOT 159
10.1.9 HELMER SCIENTIFIC 161
TABLE 86 HELMER SCIENTIFIC: BUSINESS OVERVIEW 161
10.1.10 VESTFROST SOLUTIONS A/S 164
TABLE 87 VESTFROST SOLUTIONS A/S: BUSINESS OVERVIEW 164
10.1.11 JEIO TECH INC. 165
TABLE 88 JEIO TECH INC.: BUSINESS OVERVIEW 165
10.1.12 DEEPEE COOLING PRODUCTS 166
TABLE 89 DEEPEE COOLING PRODUCTS: BUSINESS OVERVIEW 166
10.1.13 BERLINGER & CO. AG 167
TABLE 90 BERLINGER & CO. AG: BUSINESS OVERVIEW 167
10.1.14 MONNIT CORPORATION 169
TABLE 91 MONNIT CORPORATION: BUSINESS OVERVIEW 169
10.1.15 ZHEJIANG HELI REFRIGERATION EQUIPMENT CO. LTD. 171
TABLE 92 ZHEJIANG HELI REFRIGERATION EQUIPMENT CO. LTD.: BUSINESS OVERVIEW 171
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
10.2 OTHER PLAYERS 173
10.2.1 QINGDAO CAREBIOS BIOLOGICAL TECHNOLOGY CO., LTD 173
10.2.2 EBAC CO., LTD. 174
10.2.3 BIOTECNO 175
10.2.4 ZHONGKE MEILING CRYOGENICS CO., LTD. 176
10.2.5 BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD. 177
10.2.6 STERICOX INDIA PRIVATE LIMITED 178
10.2.7 ENVIRO TECHNOLOGIES 179
10.2.8 WITHNELL SENSORS 179
10.2.9 TECNOSOFT SRL 180
10.2.10 PHILIPP KIRSCH GMBH 181
11 APPENDIX 183
11.1 DISCUSSION GUIDE 183
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 187
11.3 RELATED REPORTS 189
11.4 AUTHOR DETAILS 190